Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer
Crossref DOI link: https://doi.org/10.1007/s00345-015-1655-8
Published Online: 2015-08-13
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kaufmann, S.
Bedke, J. http://orcid.org/0000-0003-2778-3108
Gatidis, S.
Hennenlotter, J.
Kramer, U.
Notohamiprodjo, M.
Nikolaou, K.
Stenzl, A.
Kruck, S.
Text and Data Mining valid from 2015-08-13